Chronic HBV infection remains a major global health burden, with current antiviral therapies effectively suppressing viral ...

In an article published in Mucosal Immunology, scientists show that IgA antibodies present in mucous membranes play a key ...

From antibody–drug conjugates (ADCs) moving into early-stage disease to arenavirus-based immunotherapies and ctDNA-guided ...

Discover how zinc paired with vitamins C, D, E, A, and elderberry supports immune function. Learn how these combinations may ...

CERo CEO Chris Ehrlich stated, "We continue to be open for business as usual and remain committed to maximizing value for our ...

The global rise in obesity has emerged as a major public health challenge, closely linked to chronic systemic inflammation ...

On December 3, 2025 (local time in Arizona, USA), ImmVira Group ('ImmVira' or the 'Company') announced a poster presentation ...

YOU MIGHT KNOW them as the “powerhouses of the cell,” but that’s selling mitochondria short—these microscopic MVPs play a ...

Colorectal cancer immunotherapy advances as Photobacterium angustum identified to selectively colonize tumors with minimal ...

GSK teams with LTZ Therapeutics to co-develop next-gen myeloid-cell engager immunotherapies in oncology leveraging LTZ’s innate-immune platform and GSK’s development engine.

At 47, I haven’t taken a day off work sick – well, and I’m racking my brains here, but I’m pretty sure… ever. I called in ...

The main market opportunities lie in developing CD40-targeting therapies, including agonists for cancer immunotherapy and antagonists for autoimmune diseases. Innovations focus on overcoming systemic ...